Sepsis and septic shock

败血症 医学 重症监护医学 感染性休克 全身炎症反应综合征 全身炎症 炎症 免疫学
作者
Richard S. Hotchkiss,Lyle L. Moldawer,Steven M. Opal,Konrad Reinhart,Isaiah R. Turnbull,Jean‐Louis Vincent
出处
期刊:Nature Reviews Disease Primers [Nature Portfolio]
卷期号:2 (1): 16045-16045 被引量:1974
标识
DOI:10.1038/nrdp.2016.45
摘要

For more than two decades, sepsis was defined as a microbial infection that produces fever (or hypothermia), tachycardia, tachypnoea and blood leukocyte changes. Sepsis is now increasingly being considered a dysregulated systemic inflammatory and immune response to microbial invasion that produces organ injury for which mortality rates are declining to 15–25%. Septic shock remains defined as sepsis with hyperlactataemia and concurrent hypotension requiring vasopressor therapy, with in-hospital mortality rates approaching 30–50%. With earlier recognition and more compliance to best practices, sepsis has become less of an immediate life-threatening disorder and more of a long-term chronic critical illness, often associated with prolonged inflammation, immune suppression, organ injury and lean tissue wasting. Furthermore, patients who survive sepsis have continuing risk of mortality after discharge, as well as long-term cognitive and functional deficits. Earlier recognition and improved implementation of best practices have reduced in-hospital mortality, but results from the use of immunomodulatory agents to date have been disappointing. Similarly, no biomarker can definitely diagnose sepsis or predict its clinical outcome. Because of its complexity, improvements in sepsis outcomes are likely to continue to be slow and incremental. Sepsis is the dysregulated systemic inflammatory and immune response to infection that produces organ injury. Septic shock is characterized by persistent hypotension that substantially increases the risk of death. In this Primer, the authors outline the controversies in sepsis and septic shock, including the complex mechanistic factors and management of critically ill patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
扎西吉宗发布了新的文献求助10
1秒前
天天快乐的应助被小鱼采纳,获得10
1秒前
大可发布了新的文献求助10
1秒前
苹果万恶完成签到 ,获得积分10
1秒前
Ba Feng发布了新的文献求助10
2秒前
中中中完成签到,获得积分10
3秒前
ee发布了新的文献求助10
3秒前
221008zn完成签到,获得积分10
3秒前
初景的应助被chen采纳,获得20
4秒前
欢喜的雨竹的应助被无私的遥采纳,获得50
4秒前
RiCh发布了新的文献求助10
4秒前
233333发布了新的文献求助10
4秒前
大聪明发布了新的文献求助10
5秒前
小火车发布了新的文献求助10
6秒前
星辰大海的应助被碧蓝梦寒采纳,获得10
6秒前
6秒前
6秒前
可爱的函函的应助被Zzz采纳,获得10
7秒前
yjh完成签到,获得积分10
7秒前
7秒前
Maestro_S的应助被蓝月采纳,获得10
9秒前
11秒前
GTY发布了新的文献求助10
11秒前
11秒前
Bill完成签到,获得积分10
12秒前
13秒前
sheetung完成签到,获得积分10
13秒前
在水一方的应助被whs采纳,获得10
13秒前
13秒前
中中中发布了新的文献求助10
13秒前
顺利代亦发布了新的文献求助10
13秒前
13秒前
思源的应助被害怕的奇异果采纳,获得10
14秒前
完美世界的应助被王泰一采纳,获得10
15秒前
礼拜一发布了新的文献求助10
15秒前
15秒前
顾矜的应助被王泰一采纳,获得10
15秒前
bkagyin的应助被王泰一采纳,获得10
15秒前
科研通AI2S的应助被王泰一采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172327
求助须知:如何正确求助?哪些是违规求助? 9564990
关于积分的说明 21777687
捐赠科研通 7763968
什么是DOI,文献DOI怎么找? 3431223
关于科研通互助平台的介绍 2555098
邀请新用户注册赠送积分活动 2476246